A detailed history of Royal Bank Of Canada transactions in Pfizer Inc stock. As of the latest transaction made, Royal Bank Of Canada holds 18,096,691 shares of PFE stock, worth $506 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares
18,096,691
Previous 20,971,597 13.71%
Holding current value
$506 Million
Previous $604 Million 16.83%
% of portfolio
0.12%
Previous 0.15%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$25.89 - $29.73 $74.4 Million - $85.5 Million
-2,874,906 Reduced 13.71%
18,096,691 $502 Million
Q4 2023

Feb 14, 2024

SELL
$26.13 - $33.94 $10.9 Million - $14.2 Million
-418,026 Reduced 1.95%
20,971,597 $604 Million
Q3 2023

Nov 14, 2023

SELL
$32.09 - $37.51 $108 Million - $126 Million
-3,353,225 Reduced 13.55%
21,389,623 $709 Million
Q2 2023

Aug 14, 2023

BUY
$36.12 - $41.79 $124 Million - $144 Million
3,441,924 Added 16.16%
24,742,848 $908 Million
Q1 2023

May 15, 2023

SELL
$39.39 - $51.28 $164 Million - $214 Million
-4,164,772 Reduced 16.35%
21,300,924 $869 Million
Q4 2022

Feb 14, 2023

BUY
$41.75 - $54.5 $92.1 Million - $120 Million
2,205,588 Added 9.48%
25,465,696 $1.31 Billion
Q3 2022

Nov 14, 2022

SELL
$43.76 - $53.42 $91.9 Million - $112 Million
-2,101,194 Reduced 8.29%
23,260,108 $1.02 Billion
Q2 2022

Aug 15, 2022

SELL
$46.53 - $55.17 $74.2 Million - $87.9 Million
-1,593,788 Reduced 5.91%
25,361,302 $1.33 Billion
Q1 2022

May 16, 2022

SELL
$45.75 - $56.69 $28.3 Million - $35 Million
-618,016 Reduced 2.24%
26,955,090 $1.4 Billion
Q4 2021

Feb 14, 2022

BUY
$41.32 - $61.25 $54.3 Million - $80.5 Million
1,314,618 Added 5.01%
27,573,106 $1.63 Billion
Q3 2021

Nov 15, 2021

BUY
$39.25 - $50.42 $35.3 Million - $45.4 Million
899,716 Added 3.55%
26,258,488 $1.13 Billion
Q2 2021

Aug 16, 2021

BUY
$35.91 - $40.68 $911 Million - $1.03 Billion
25,358,772 New
25,358,772 $993 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $157B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Royal Bank Of Canada Portfolio

Follow Royal Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.